Compare Cintas Corporation (CTAS) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cintas Corporation vs Novartis AG — how do they compare? Cintas Corporation trades at $205.28 (market cap $82.15B), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 3.6× Cintas Corporation's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| CTAS | NVS | |
|---|---|---|
Market Cap | $82.15B | $295.37B |
Sector | Industrials | Health |
52-Week High | $225.10 | $168.62 |
52-Week Low | $163.55 | $119.31 |
Enterprise Value | $84.56B | $336.69B |
Dividend Yield | 1.01% | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
